Effectiveness of Cannabis Sativa-Infused Drip Tea on Happiness Among Individuals Interested in Medical Cannabis-Based Care: A Quasi-Experimental Study
Abstract
Objective: Every human being desires to be happy. Cannabis is a plant that contains cannabinoid compounds that have pharmacological effects, with mood-altering properties. Therefore, the objective of this study was to investigate the acceptance and effects of cannabis-infused drip tea on happiness levels.
Material and Methods: Thirty volunteers interested in cannabis-based healthcare were selected using a purposive sampling method. The sample was divided into three groups (10 people/group, with each group receiving drip tea infused with 3%, 5%, and 7% w/w cannabis). The tea was prepared by steeping cannabis leaves in hot water for 30 minutes. Participants consumed the cannabis-infused drip tea daily before bedtime for a week.
Results: The results demonstrated a statistically significant increase in happiness levels between pre-experimental and post-experimental groups, indicating that cannabis-infused tea had a positive effect on participants’ well-being. Among the formulations tested, the 7% w/w cannabis-infused drip tea yielded the highest level of happiness score. These results highlight the potential use of cannabis-infused tea in increasing happiness levels compared to typical baseline levels.
Conclusion: The use of herbal teas is a traditional approach employed by Thai traditional and folk medicine practitioners for health promotion and treatment. The findings from this study support the potential application of cannabis-infused tea in improving happiness levels. However, further studies are recommended to explore the long-term consumption of cannabis-infused tea to determine its efficacy and safety.
Keywords
Full Text:
PDFReferences
Assanangkornchai S, Thaikla K, Talek M, Saingam D. Medical cannabis use in Thailand after its legalization: a respondent-driven sample survey. Peer J 2022;10:12809.
Zinboonyahgoon N, Srisuma S, Limsawart W, Rice ASC, Suthisisang C. Medicinal cannabis in Thailand: 1-year experience after legalization. PAIN 162;105-9.
Government of Thailand. Narcotics Act. B.E.2019. Bangkok: Royal Thai Government; 2019.
Laohavanich M. Political economy of cannabis in Thailand. Chula Med J 2022;66:11.
Department of Medical Services, Ministry of Public Health. Guidance on cannabis for medical use. Nonthaburi: Ministry of Public Health; 2021.
Committee for Public Relations on Medical Cannabis of the Ministry of Public Health. Medical cannabis clinic. Nonthaburi: Ministry of Public Health; 2021.
Amin MR, Ali DW. Pharmacology of medical cannabis. In: Bukiya A, editor. Recent advances in cannabinoid physiology and pathology. advances in experimental medicine and biology. Cham: Springer; 2019.
Maioli C, Mattoteia D, Amin HIM, Minassi A, Caprioglio D. Cannabinol: History, Syntheses, and Biological Profile of the Greatest “Minor” Cannabinoid. Plants 2022;11:2896.
Esther MB, Maria MS, Manzanares J, Charles RM. Cannabidiol as a potential treatment for anxiety disorders. Neurotherapeutics 2015;12:825-36.
Ferber SG, Namdar D, Hen-Shoval D, Eger G, Shoval HKG, Shbiro L, et al. The “Entourage Effect”: Terpenes Coupled with Cannabinoids for the Treatment of Mood Disorders and Anxiety Disorders. Curr Neuropharmacol 2020;18:87-96.
Sevigny EL, Greathouse J, Medhin DN. Health, safety, and socioeconomic impacts of cannabis liberalization laws: an evidence and gap map. Campbell Syst Rev 2023;19:1362.
Whynot EG, Tomko AM, Dupré DJ. Anticancer properties of cannabidiol and Δ9-tetrahydrocannabinol and synergistic effects with gemcitabine and cisplatin in bladder cancer cell lines. J Cannabis Res 2023;5-7.
Ransing R, Rosa PA, Pereira SV, Handuleh JIM, Jerotic S, Gupta AK. Current state of cannabis use, policies, and research across sixteen countries: cross-country comparisons and international perspectives. Trends Psychiatry Psychother 2021;44:e20210263.
Hasin DS. US epidemiology of cannabis use and associated problems. Neuropsychopharmacology 2018;43:195-212.
Morean ME, Lederman IR. Prevalence and correlates of medical cannabis patients’ use of cannabis for recreational purposes. Addict Behav 2019;93:233-9.
Abuhasira R, Schleider LB, Mechoulam R, Novack V. Epidemiological characteristics, safety and efficacy of medical cannabis in the elderly. Eur J Intern Med 2018;49:44-50.
Kosiba JD, Maisto SA, Ditre JW. Patient-reported use of medical cannabis for pain, anxiety, and depression symptoms: Systematic review and meta-analysis. Soc Sci Med 2019;233:181-92.
Charoenporn V, Charernboon T, Mackie CJ. Medical Cannabis as a Substitute for Prescription Agents: A Systematic Review and Meta-analysis. J Subst Use 2022;1–13.
Smith CB, Schmidt J, Holdsworth EA, Caffé B, Brooks O, Williams JE, et al. Cannabis use, decision making, and perceptions of risk among breastfeeding individuals: the Lactation and Cannabis (LAC) Study. J Cannabis Res 2024;6:6.
Charernboon T, Lerthattasilp T, Supasitthumrong T. Effectiveness of Cannabinoids for Treatment of Dementia: A Systematic Review of Randomized Controlled Trials. Clin Gerontol 2021;44:16–24.
Davidson WM, Mahavni A, Chrusciel T, Salas J, Miller LR, Sullivan MD, et al. Characteristics of patients with non-cancer pain and long-term prescription opioid use who have used medical versus recreational Marijuana. J Cannabis Res 2024;6:7.
Yiengprugsawan V, Somboonsook B, Seubsman SA, Sleigh AC. Happiness, Mental Health, and Socio-Demographic Associations Among a National Cohort of Thai Adults. J Happiness Stud 2012;13:1019-29.
Dsouza JM, Chakraborty A, Veigas J. Biological Connection to the Feeling of Happiness. J Clin Diagn Res 2020;14:VEO1-5.
Dfarhud D, Malmir M, Khanahmadi M. Happiness & Health: The Biological Factors- Systematic Review Article. Iran J Public Health 2014;43:1468-77.
Steptoe A. Happiness and Health. Annu Rev Public Health 2019;40:339-59.
He K. Traditional Chinese and Thai medicine in a comparative perspective. Complement Ther Med 2015;23:821-26.
Tipduangta P, Julsrigival J, Chaithatwatthana K, Pongterdsak N, Tipduangta P, Chansakaow S. Antioxidant Properties of Thai Traditional Herbal Teas. Beverages 2019;5:44.
Kanjanahattakij N, Kwankhao P, Vathesatogkit P, Thongmung N, Gleebbua Y, Sritara P, et al. Herbal or traditional medicine consumption in a Thai worker population: pattern of use and therapeutic control in chronic diseases. BMC Complement Altern Med 2019;19:258.
Tongkasee P, Srithat, D, Sriyasak P, Sriyasak P, Jitcharerntham A, Piwgern T, et al. Formulation and Phytochemical Profile of a Product Prototype Infused with Cannabis sativa Leaves. Trends Sci 2023;20:5835.
Srithat D, Tongkasee P. Effectiveness of Cannabis-containing Tea on Insomnia. Health Sci J Thai 2022;5:25-32.
Świąder K, Florowska A, Konisiewicz Z. The sensory quality and the textural properties of functional oolong tea-infused set type yoghurt with inulin. Foods 2021;10:1242.
Kassambara A. RSTATIX. Pipe-friendly framework for basic statistical test [serial on the Internet]. [cited 2024 Jan 10]. Available from: https://rpkgs.datanovia.com/rstatix/ index.html
R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing [serial on the Internet]. [cited 2024 Jan 10]. Available from: https://www.R-project.org/
Spillane NS, Schick MR, Hostetler KL, Trinh CD, Kahler CW. Results of a pilot study examining the effect of positive psychology interventions on cannabis use and related consequences. Contemp Clin Trials 2023;131:107247.
Pitanupong J, Vatcharasinthu S, Jatchavala C. Covid-19 Patients with First-Diagnosed Substance Use Disorders in Southern Thailand: A Study from a Field Hospital. J Health Sci Med Res 2024;43:20241070.
Jatchavala C. Interventions during the copycat suicide crisis among Thai students: A follow-up study. J Med Soc 2023;37:68–75.
Chandra S, Lata H, ElSohly MA. Propagation of Cannabis for Clinical Research: An Approach Towards a Modern Herbal Medicinal Products Development. Front Plant Sci 2020;26:958.
Schmid Y, Scholz I, Mueller L, Exadaktylos AK, Ceschi A, Liechti ME, et al. Emergency department presentations related to acute toxicity following recreational use of cannabis products in Switzerland. Drug Alcohol Depend 2020;206:107726.
Madeo G, Kapoor A, Giorgetti R, Busardò FP, Carlier J. Update on Cannabidiol Clinical Toxicity and Adverse Effects: A Systematic Review. Curr Neuropharmacol 2023;21:2323-42.
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.